Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence (AI) for integrating and analyzing genomic, transcriptomic, proteomic, and patient-derived data to identify, characterize, and prioritize disease-associated proteins, peptides, biomarkers, and therapeutic targets in the field of drug discovery

'ai':13 'aiaa':6 'analyz':17 'artifici':1,11 'associ':33 'biomark':36 'character':28 'data':25 'deriv':24 'discoveri':45 'diseas':32 'disease-associ':31 'drug':44 'featur':8 'field':42 'genom':18 'identifi':27 'integr':15 'intellig':2,12 'patient':23 'patient-deriv':22 'peptid':35 'priorit':30 'protein':34 'proteom':20 'servic':5,7 'softwar':9 'target':39 'therapeut':38 'transcriptom':19 'use':10

DARKCYPHER

Owner

Goods & Services